Dysregulated molecular networks in head and neck carcinogenesis
about
Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancerThe determinants of head and neck cancer: Unmasking the PI3K pathway mutationsMutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment responsePhase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.Microgenomics of ameloblastomaImproving oral cancer survival: the role of dental providersContemporary management of cancer of the oral cavity.Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial.Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.Helicobacter pylori and oral pathology: relationship with the gastric infectionImplication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cellsHistones: Controlling Tumor Signaling CircuitryOpposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells.Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patientsLow-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathwayQuantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesAnti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental modelsc-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptaseRSK activation of translation factor eIF4B drives abnormal increases of laminin γ2 and MYC protein during neoplastic progression to squamous cell carcinoma.Clinico-Pathological Correlation of β-Catenin and Telomere Dysfunction in Head and Neck Squamous Cell Carcinoma PatientsCommon oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian originReceptor-tyrosine-kinase-targeted therapies for head and neck cancer.The molecular pathogenesis of head and neck cancer.NF-κB addiction and its role in cancer: 'one size does not fit all'.Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model.A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancersMethylation-mediated molecular dysregulation in clinical oral malignancyRole of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.Luteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma.
P2860
Q28488474-9137E33D-6427-4496-BE79-37E0B736F469Q30365726-2A124CDD-C9AB-435B-B631-1463B62D65BFQ31162700-16DEB5AA-0CD9-4238-87EC-4BC50437D5C5Q33412801-F6E66AC2-0F5D-43B4-955E-75522F09B0D5Q33720509-15E4BF9B-AA2F-4B8A-A101-9D3B28B67D4BQ33771631-F8A9E98B-FFD1-493E-9FCB-BE7ED0AD9177Q33808215-501187D8-2C2B-4459-9977-C5B45D257B56Q33837563-F6314949-47CF-4EFC-95AE-A4C8A20D1B3BQ33866803-35431F43-9030-46C1-9715-AD02ADB80C3BQ33902520-C007FC24-3DD1-44DC-B5D2-815EB5B7D242Q33927058-D2B1C9E5-EA12-4DDD-AC85-59B8D4742DE5Q34008814-8B28BF0D-E0F4-40B6-98D7-BE6FE543EA6EQ34053287-3ABBC48B-3C1B-4247-ABD9-5013C45D2C75Q34109472-86BB0EC1-C16D-497E-B950-CEEC25E42336Q34160427-E8D68891-AE8B-47D1-9163-76025B45D174Q34206164-99DF6DB3-073D-4024-8915-324743CB710AQ34303695-590D59F9-C144-49A9-91F9-66FF80D760C1Q34348741-8F5A2491-6B2B-4EB8-97BB-960CAC7AF4C4Q34383791-ED26D921-7003-4EE6-B8EE-C88BC5DD8320Q34647479-C0AE6E21-AD48-4206-B017-45EEA3B0613BQ34661396-6A9E16C8-DE50-4DFA-8BC2-91619125ACFAQ34704903-F7B3F101-2D5D-42D3-8498-B15D441C3304Q34760619-E4FC8486-8C96-4192-8E5E-7FFD5FFE3083Q34788361-65BD0686-5952-4B14-92C9-4413FC0B04CCQ34883707-16B32690-6935-47CA-9F78-CC3BF93F9E23Q35036869-CF75B098-CFF9-4AC1-B0BD-B7D13F6CE3C9Q35040935-6E289314-9E89-4924-9FC8-C44494F4E3B2Q35041632-6E6DEAFF-E29C-4FAA-BDC7-5958EF098363Q35102025-18F9C4A9-FDF9-4469-9C8F-CB2A32FC60F9Q35111736-0C07BEA5-7EEF-4462-BB07-B1E72A4A30CBQ35120893-AA51AD9C-60E7-4315-8B33-1B5576598071Q35675984-49105440-0C7A-4F50-B224-9C6B900E74B0Q35722714-BE8A7B9C-574C-4200-9FCC-54D1A39AD18EQ35741628-BA1D62D9-BE30-4D78-92EB-12667B798E93Q35742458-AA21740B-D24F-4EFB-B02B-DF40CF359DB0Q35925179-11949398-F783-458E-83FA-E729A2A8869CQ35974424-437048CE-D6EF-46EE-9D40-916D709EC433Q35994228-D34644B6-64DD-49EF-BFA4-92395D8E37A4Q36029715-BFB0410D-B826-4115-9938-49B9B3E17D87Q36042031-63B63A6C-72E5-4EC7-9FAF-D7CB7D920573
P2860
Dysregulated molecular networks in head and neck carcinogenesis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dysregulated molecular networks in head and neck carcinogenesis
@en
Dysregulated molecular networks in head and neck carcinogenesis.
@nl
type
label
Dysregulated molecular networks in head and neck carcinogenesis
@en
Dysregulated molecular networks in head and neck carcinogenesis.
@nl
prefLabel
Dysregulated molecular networks in head and neck carcinogenesis
@en
Dysregulated molecular networks in head and neck carcinogenesis.
@nl
P2093
P2860
P1433
P1476
Dysregulated molecular networks in head and neck carcinogenesis
@en
P2093
Alfredo A Molinolo
Cristiane H Squarize
J Silvio Gutkind
Panomwat Amornphimoltham
Rogerio M Castilho
Vyomesh Patel
P2860
P304
P356
10.1016/J.ORALONCOLOGY.2008.07.011
P407
P577
2008-09-19T00:00:00Z